Bearish options activity surges in Medtronic plc (MDT) despite long-term growth prospects

Bearish options activity surges in Medtronic plc (MDT) despite long-term growth prospects
Bearish options activity surges in Medtronic plc (MDT) despite long-term growth prospects

We recently compiled a list of the The 7 Most Promising Robotics Stocks According to Wall Street Analysts. Medtronic plc ranks fifth among most promising actions.

TheFly reported on December 18 that Truist Securities maintained its Hold rating on MDT but lowered its price target to $107.00 from $110.00. This review followed an update to the company’s valuation models for the medical device sector. Analyst Richard Newitter noted that while MDT’s long-term growth prospects remain intact, the near-term valuation is balanced by macroeconomic headwinds.

Separately, on December 22, market sentiment took a turn when TipRanks and other financial outlets reported that Medtronic plc (NYSE:MDT) sales volume was unusually high and directionally bearish. This increase in bearish options activity coincided with the company’s recent operational updates, suggesting that traders were hedging against potential downsides despite the positive regulatory news.

Bearish options activity surges in Medtronic plc (MDT) despite long-term growth prospects
Bearish options activity surges in Medtronic plc (MDT) despite long-term growth prospects

Recently, on December 19, 2025, the company filed a registration statement on Form S-1 to spin off its Diabetes business as MiniMed, and is expected to list on Nasdaq under MMED. The separation allows MDT to focus on higher growth segments, while MiniMed can pursue its own innovation strategy in diabetes care.

Medtronic plc (NYSE:MDT) is a global medical technology company headquartered in Galway, Ireland, providing innovative therapies and medical devices for cardiac, diabetic, surgical and neurological care. From a robotics perspective, MDT is a leader in surgical robotics and AI-enabled platforms, including the Hugo robot-assisted surgery system and advanced navigation ecosystems that improve precision in minimally invasive procedures.

While we recognize MDT’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.

READ NEXT: 30 stocks that should double in 3 years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.

Source link